Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_4
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(1)
Terminated(1)
Other(2)

Detailed Status

unknown2
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
50.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (100.0%)

Trials by Status

unknown250%
terminated125%
completed125%

Recent Activity

0 active trials
Showing 4 of 4
unknown

Semitendinosus Graft as Meniscal Transplant

NCT04753424
unknown

Outflow Reconstruction in Right Lobe Living Donor Liver Transplantation

NCT03666689
completed

Antimullerian Hormone in Endometriomas

NCT02669628
terminatedphase_4

MINIMALLY INVASIVE SURGERY in Total Knee Arthroplasty

NCT00853398

Clinical Trials (4)

Showing 4 of 4 trials
NCT04753424

Semitendinosus Graft as Meniscal Transplant

Unknown
NCT03666689

Outflow Reconstruction in Right Lobe Living Donor Liver Transplantation

Unknown
NCT02669628

Antimullerian Hormone in Endometriomas

Completed
NCT00853398Phase 4

MINIMALLY INVASIVE SURGERY in Total Knee Arthroplasty

Terminated

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4